sustainability and transition: re-framing the issues · joe kutzin, who sharing and debating...

25
Joe Kutzin, WHO Sharing and Debating Country Experiences on Health Financing Reform Health Financing Technical Network Meeting 14 December 2016, Geneva, Switzerland Sustainability and Transition: re-framing the issues

Upload: others

Post on 24-May-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Joe Kutzin, WHO

Sharing and Debating Country Experiences on

Health Financing Reform

Health Financing Technical Network Meeting 14 December 2016, Geneva, Switzerland

Sustainability and Transition:

re-framing the issues

2 |

TRANSITION AS A MOTIVATOR

3 |

Recognition of limits of donor funding, especially given global financial / economic situation

Big funders (e.g. GFATM, Gavi) seeking to prioritize/target across countries as part of their need to cope with fewer resources

– e.g. Equitable Access Initiative

WHO health programs have also identified this as a major concern, leading to growing interest in revenue sources to ensure sustainability of “my program”

– DRM and “innovative financing”

Growing concerns over past few years from

GHIs and health programs

4 |

What is real in the transition from aid

Many countries can expect a decline in aid

When this happens, total spending moves faster than

public spending

Therefore, countries need to:

– Strengthen public finance, increase tax capacity, etc.

– Improve efficiency to get more from the money they spend on

health

What we observe in practice: The “Health

Financing Transition” from aid

Total health expenditure per capita (left axis)

LOW INCOME

LOWERMIDDLEINCOME

UPPERMIDDLEINCOME HIGH INCOME

52

51

00

500

250

01

00

00

Tota

l h

ea

lth e

xp

en

ditu

re p

er

cap

ita, U

S$

250 500 1000 2500 10000 35000 100000GNI per capita, US$

Source: WHO

Health financing transition

Sourc

e o

f slid

e: A

jay T

andon, W

orld

Bank

What we observe in practice: The “Health

Financing Transition” from aid

Total health expenditure per capita (left axis)

External share (right axis)

LOW INCOME

LOWERMIDDLEINCOME

UPPERMIDDLEINCOME HIGH INCOME

01

02

03

04

05

0

Sh

are

of to

tal he

alth

exp

en

ditu

re (

%)

52

51

00

500

250

01

00

00

Tota

l h

ea

lth e

xp

en

ditu

re p

er

cap

ita, U

S$

250 500 1000 2500 10000 35000 100000GNI per capita, US$

Source: WHO

Health financing transition

Sourc

e o

f slid

e: A

jay T

andon, W

orld

Bank

What we observe in practice: The “Health

Financing Transition” from aid

Total health expenditure per capita (left axis)

External share (right axis)

OOP share (right axis)

LOW INCOME

LOWERMIDDLEINCOME

UPPERMIDDLEINCOME HIGH INCOME

01

02

03

04

05

0

Sh

are

of to

tal he

alth

exp

en

ditu

re (

%)

52

51

00

500

250

01

00

00

Tota

l h

ea

lth e

xp

en

ditu

re p

er

cap

ita, U

S$

250 500 1000 2500 10000 35000 100000GNI per capita, US$

Source: WHO

Health financing transition

Sourc

e o

f slid

e: A

jay T

andon, W

orld

Bank

8 |

And don’t tell anyone, but…

For those countries not experiencing transition, important

health financing priorities are to…

– Strengthen public finance, increase tax capacity, etc.

– Improve efficiency to get more from the money they spend on

health

So let’s use the momentum attached to transition to

reinvigorate efforts to do what should already have been

done in any case

9 |

The international response has largely

focused on revenues

How much can we raise from “innovative financing”,

lobbying the MOF, and donor funding to meet our “magic

number” targets?

Health programs and their partners each addressing

these issues and approaching Finance Ministries

– …for sustainability of their program (HIV/AIDS, NCDs, NTDs,

nutrition, RMNCAH, TB, malaria,…)

10 |

Some concerns

We can’t (or shouldn’t) be arguing that every important

disease deserves its own tax and revenue stream

Sustainability is not only a revenue question; we have to

think about managing expenditures better to get better

results from our spending

– “Can’t just spend your way to UHC”

Need comprehensive rather than piecemeal engagement

between health and finance

11 |

A POSSIBLE WAY FORWARD

12 |

We need to learn from the MDG era, and put

the “S” in SDG!

Great progress made on critical health issues

But also unintended consequences – MDGs stimulated fragmentation: separate plans, budget,

funding, procurement, monitoring, etc.

– SDG targets may lead to continued emphasis on vertical approaches: more separate plans, monitoring mechanisms, funding streams and implementation efforts; with only limited investment in harmonization and alignment across programs

The UHC target can provide “umbrella” to enable move away from silos and fragmentation

– Requires much more active collaboration with programs within the health sector, and focus on prioritization within unified national health strategies

13 |

What is needed to take this in a more

productive direction?

Get the questions right

Use the appropriate unit of analysis

Without these two fundamentals, all the tools and

techniques we have at our disposal can easily be mis-

used

14 |

Getting the sustainability question right

Not this:

– How can we make the TB (or HIV, or immunization, or MCH,

or…) program sustainable?

Instead this:

– How can we sustain increased effective coverage of priority

interventions?

– Because almost certainly, we can’t do it with 5 procurement

systems, 3 information systems, fragmented governance,

distorted HRH incentives, etc. etc.

15 |

…emerged when public health programs were seen as

sufficiently “different” to require entirely separate

arrangements for all health system functions:

– Consequences of communicable diseases certainly require

heavy subsidy or should be fully free

– But there is no a priori reason for separate pooling and

purchasing arrangements

– Same with service delivery

– And certainly not separate information, procurement, supply

chain, governance, HRH, etc.

The vertical program (silo) problem…

There seems to be an inverse relation between a

country’s level of income and the complexity of

its financial flows: can we move away from this?

17 |

What a “UHC lens” brings to this issues

Unit of analysis is the system, not the program or single

disease

– Budget dialog makes sense at sectoral level, not disease-by-

disease

– Assess progress at level of population, not for “scheme

members” or program beneficiaries

– Just as an insurance scheme can make its members better off at

the expense of the rest of the population, so too with a health

program

– Similarly with efficiency, need a whole system, whole population

unit of analysis (the cross-programmatic approach)

B A

Le

vel of goal att

ain

ment

Level of resource inputs

maximum attainable for

given resource input level

Adapted from P. Travis

An efficiency agenda is central to the ability of

governments to sustain progress on their

coverage goals (not their programs)

Not just a concept: empirically, wide variation in

performance at similar expenditure levels

Service coverage: systematic increase in performance with increased public spending; also systematic fall in variation across countries (less poor performers).

Financial protection: performance increases in Q4 and Q5. High variation remains.

10%

20%

30%

40%

50%

60%

70%

80%

90%

100

%

Q1 Q2 Q3 Q4 Q5

Q1 to Q5 denote quintiles of public spending on health per capita, US$(PPP)

Financial protection (proxy)Average all service coverage indicators

n=16 or 17

<$37 $38 to $59 $61 to $198 $207 to $500 >$520

Jow

ett e

t al. (2

016). S

pendin

g ta

rgets

for h

ealth

:

no m

agic

num

ber. W

HO

.

20 |

Be clear on what are we trying to sustain

Neither “health programs” nor even “health systems”

– These are means, not ends

Aim of policy is to improve performance (mix of health

system goals, as e.g. embodied in UHC) to the extent

possible subject to the constraint of living within our

budget

Therefore, what we want to sustain is increased effective

coverage of priority interventions

21 |

How to meet the challenge?

Look beyond just revenues

Not about meeting a “magic” target or “innovative

financing”, donor funds, investment cases for a particular

program

Health programs and their partners each

addressing these issues and approaching finance for

sustainability of their own program (HIV/AIDS, NCDs,

NTDs, nutrition, RMNCAH, TB, malaria,…)

Can’t (and shouldn’t) argue that every important disease

needs its own tax and revenue stream

22 |

We need to move from silos to

sustainability

Imagine you are a Minister of Health of a newly middle-

income country, confronted with all of these demands,

as well as learning that because of your country’s

economic progress, donors will reduce their funding…

– You are responsible for the entire sector, and you have to

make better use of all of your resources

– Aim to streamline system architecture across programs

while ensuring good results

But enabling efficiency gain may actually require

investment

– Potentially large agenda to strengthen underlying systems

23 |

CONCLUSION AND SOME

QUESTIONS FOR DISCUSSION

24 |

An approach to sustaining improvement

through the transition

Ensure that the sustainability and transition agenda is not only about revenues; the expenditure/institutional side (improving efficiency) must be part of the dialog

Ensure unit of analysis is system level, not program level

Maintain or even increase accountability for results that is typically associated with “health programs”, focusing on

– Clear accountability for ensuring delivery of priority, quality services to the populations that need them (i.e. effective coverage)

– Reduce costs to the system of doing this (e.g. addressing duplication and overlap) so that progress towards coverage goals can be sustained

25 |

Some questions to consider for discussion

How does this “transition” debate play out at country level? – Is it all about spending gaps or reference to global targets?

Is efficiency on the agenda? What are you doing about it? – Efficiency only within programs/schemes, but also across them

(dealing with duplication, overlap?)

– Reforms and/or investments needed?

Are there points of conflict between country and “donor” perspectives and priorities? Can we identify these so that they can be addressed? Where do views converge?

What differences in priorities and perspectives between “programs” and MOH? Implications?